Kazia Therapeutics Limited - ADR earnings per share and revenue
On 07. Nov. 2025, KZIA reported earnings of 1.42 USD per share (EPS) for Q4 25, beating the estimate of -1.32 USD, resulting in a 207.09% surprise. Revenue reached 42.00 tausend, compared to an expected 8.16 tausend, with a 414.71% difference. The market reacted with a +0.82% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Kazia Therapeutics Limited - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Kazia Therapeutics Limited - ADR reported EPS of $1.42, beating estimates by 207.09%, and revenue of $42.00K, 414.71% above expectations.
How did the market react to Kazia Therapeutics Limited - ADR's Q4 2025 earnings?
The stock price moved up 0.82%, changed from $7.33 before the earnings release to $7.39 the day after.
When is Kazia Therapeutics Limited - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Kazia Therapeutics Limited - ADR's next earnings report?
Based on --
analysts, Kazia Therapeutics Limited - ADR is expected to report EPS of -- and revenue of -- for Q-- --.